Arizona Tribune - Boulevard

Demands for Church of England reform after abuse scandal

Anglican leaders faced pressure Wednesday to speed up reforms following Archbishop of Canterbury Justin Welby's resignation over a damning report concluding the Church of England covered up a serial abuse case.

China removes memorials to victims of deadliest attack in a decade

Officials in southern China ramped up security on Wednesday at the site of the country's deadliest attack in a decade, snuffing out makeshift memorials to the 35 people killed when a man drove a car into a crowd at a sports complex.

Iran hangs man 'for second time' after previous execution halted: NGO

Iran hung a 26-year-old man for a second time Wednesday months after a previous execution was halted half a minute in, an NGO said.

Indonesians drill for disaster before tsunami anniversary

Hundreds of Indonesians fled for higher ground Wednesday as they ran through disaster drills in the region worst hit by the 2004 Indian Ocean tsunami ahead of its 20th anniversary next month.

Journalist says his detention removed Guatemala's 'mask of democracy'

A prominent Guatemalan journalist and corruption critic, declared a prisoner of conscience by Amnesty International, says that his time in prison allowed him to strip away his country's "mask of democracy."

Evacuations and call for aid as Typhoon Usagi approaches Philippines

The Philippines ordered evacuations Wednesday ahead of Typhoon Usagi's arrival, as the UN's disaster office sought $32.9 million in aid for the country after recent storms killed more than 150 people.

China snuffs out memorials to victims of deadly car rampage

Officials in southern China ramped up security on Wednesday at the site of one of the country's deadliest mass-casualty events in years, snuffing out makeshift memorials to the 35 people killed when a man drove a car into a crowd at a sports complex.

Airlines around Asia ground Bali flights after volcano erupts

Airlines in Australia, Hong Kong, India, Malaysia and Singapore cancelled flights to and from the Indonesian resort island of Bali on Wednesday, after a nearby volcano catapulted an ash tower miles into the sky.

How China's censorship machine worked to block news of deadly attack

At least 35 people were killed and dozens more injured when a man ploughed his car into pedestrians exercising around a sports centre in the southern Chinese city of Zhuhai on Monday night.

Australian airlines cancel Bali flights after volcano erupts

Several Australian airlines on Wednesday cancelled their flights to and from the Indonesian resort island of Bali, after a nearby volcano catapulted an ash tower miles into the sky.

China snuffs out memorials to victims of deadly car ramming attack

Officials in southern China ramped up security on Wednesday at the site of one of the country's deadliest mass-casualty events in years, snuffing out makeshift memorials to the 35 people killed when a man drove a car into a crowd at a sports complex.

Evacuations, call for aid as Typhoon Usagi approaches Philippines

The Philippines ordered evacuations ahead of Typhoon Usagi on Wednesday, as the UN disaster office sought $32.9 million in aid for the country after storms that killed more than 150 people.

China clears memorial to victims of deadly car ramming attack

Workers in the southern Chinese city of Zhuhai removed flowers and candles early Wednesday from a makeshift memorial to 35 people killed when a man drove a car into a crowd in one of the country's deadliest mass-casualty events in years.

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue up 54% sequentially$20.1 million cash balance at September 30, 2024Organizational changes and operating optimization plan implemented to further streamline operations, reduce expenses, and accelerate path to consistent cash flowRyan Selhorn promoted to Chief Financial OfficerCompany to host conference call and webcast today, November 13, 2024, at 4:30 p.m. Eastern time

The Menninger Clinic Offering Nation’s First Rapid Targeted Transcranial Magnetic Stimulation to Treat Depression

Menninger is the only hospital in the U.S. to offer groundbreaking treatment

KindlyMD(R) Announces Third Quarter 2024 Financial Results

Q3 Reimbursements from insurance payors totaled $106,567 an increase of 16.4% sequentiallyKindlyMD now provides more than 90% in-network insurance coverage in Utah

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 3:30 pm GMT. For access, visit Amphastar's Pharmaceuticals website at http://ir.amphastar.com. This webcast will be available for 30 days following the presentation.

Mosaic Announces Quarterly Dividend of $0.21 Per Share

The Mosaic Company (NYSE:MOS) announced today that its Board of Directors declared a quarterly dividend of $0.21 per share on the Company's common stock. The dividend will be paid on December 19, 2024, to stockholders of record at the close of business on December 5, 2024.

374Water Releases Third Quarter 2024 Results and Provides Business Update

New Management Team Advances AirSCWO Technology, Operational in City of Orlando

Tenon Medical Reports Third Quarter 2024 Financial Results

~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL™ Study; Post-Market Study Supports the Safety and Efficacy of the Catamaran SI Joint Fusion System® Including Radiographic Proof of Fusion ~~ Initial Clinical Procedures Completed with New Catamaran SE Platform ~~ Granted Issuance of Three U.S. Patents ~~ Received Net Proceeds of ~$9.6 Million from Equity Financing Transactions ~

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

- Dermata nears completion of enrollment in its DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial -- Dermata continues discussions with potential botulinum toxin partners for DMT410 -- Raised $5.1 million in gross proceeds from financings completed in 3Q 2024 -

Builders, Craftsmen and Innovators Unite: Build Show LIVE Sparks a Movement in Building Science

Build Show LIVE, the brand-new tradeshow held last week in the heart of Austin, was the launch of a transformative movement, bringing together passionate builders, remodelers, architects and manufacturers from 47 states and nine countries, who are committed to elevating the future of residential construction.

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

DehydraTECH clinical test article manufacturing has been completed

Gaucho Holdings Initiates Chapter 11 Reorganization To Protect Core Assets

Strategic Filing Aims to Protect Operational Continuity for the Benefit of Stockholders

Pure Cycle Announces Financial Results For the Year Ended August 31, 2024

Pure Cycle Corporation (NASDAQ Capital Market:PCYO) announced its financial results for the year ended August 31, 2024. Pure Cycle reported $11.6 million of net income for the year ended August 31, 2024, which is a 147% increase compared to 2023, and marks our seventh consecutive year and twenty-first consecutive fiscal quarter with positive net income. Pure Cycle reported $0.48 of earnings per fully diluted common shares, which is up from $0.19 in 2023, a 153% increase. We recognized a 135% increase in lot sales revenue for the year ended August 31, 2024 compared to 2023, due to an increase in our development activity. Pure Cycle continues to develop its Sky Ranch Master Planned Community, and as of August 31, 2024, we are actively working on Phases 2A, 2B and 2C. Phase 2A and 2B are substantially completed with finished lots delivered to homebuilders. We expect home builders to be able to begin construction in Phase 2C during fiscal 2025 and to start home building in Phase 2D in fiscal 2026.

Dalet and Caretta Research Publish "Future of Newsroom Workflows" Report

Insights Reveal the Need for News Organizations to Transform Operations to Thrive in a Rapidly Changing Landscape

ANGLE presents two posters at EACR

PARSORTIX-BASED ASSAYS SHOWCASED AT THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH LIQUID BIOPSIES CONFERENCETwo posters highlight the importance of epitope-independent CTC enrichment and molecular characterisation of CTCs

Jaguar Health Reports Third Quarter 2024 Financial Results

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 million and 11% versus net Q3 2023 revenue of $2.8 millionJaguar reported significant results in breast cancer patients in its phase 3 OnTarget trial for its cancer supportive care drug crofelemer; results in breast cancer patients accepted for poster presentation on December 11, 2024 at the San Antonio Breast Cancer Symposium (SABCS)Jaguar initiated commercial launch in October 2024 for Gelclair®, the company's third prescription product, in alignment with Jaguar's focus on cancer supportive careJaguar is initiating two Phase 2 trials in Q4, 2024 and supporting multiple investigator-initiated proof-of-concept studies ("IIT") of crofelemer for the rare and orphan disease indications of microvillus inclusion disease (MVID) and short bowel syndrome (SBS) with intestinal failure in the US, EU, and Middle East/North Africa (MENA) regions; results of IITs expected by the end of 2024 and throughout 2025REMINDER: Jaguar to host investor webcast Wednesday, November 13th at 8:30 a.m. Eastern regarding Q3 2024 financials and company updates; Click here to register for webcast

Noble Roman's Announces Third Quarter 2024 Financial Data

Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub ("CPP"), today announced financial data for the third quarter 2024 and other company highlights.

Noble Roman's to Release 3rd Quarter 2024 Financial Data on November 13th; to Host Conference Call on November 14th at 4:00 PM EST

Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, announced that it will report 2024 3rd quarter financial data on Wednesday, November 13th after the markets close. Noble Roman's also announced that it will host a conference call on Thursday, November 14th from 4:00 to 4:45 PM EST. Those interested in participating in the conference call should dial in at 317-300-7896 and use the participation code 499795 (no pin number required - callers will press 5* to ask questions when Q&A time is announced).

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2024.

CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine

Company is creating its own wine. Capitalizing on the projected $2.1 billion U.S. CBD-infused beverage market by 2025, CBDL positions itself at the forefront of innovation, unlocking immense revenue potential in the booming CBD alcohol sector.

CMSC	0.18%	21.99	$
NGG	3.22%	82.85	$
RBGPF	3.73%	68.15	$
BTI	1.96%	61.77	$
GSK	4.4%	53.66	$
RYCEF	2.74%	19.68	$
RIO	1.13%	94.42	$
VOD	1.06%	13.15	$
BCE	1.87%	21.42	$
AZN	5.79%	195.15	$
BCC	0.59%	75.93	$
RELX	1.72%	31.93	$
CMSD	-0.14%	22.15	$
JRI	0.46%	13	$
BP	3.34%	37.4	$

Arizona Tribune - Boulevard (English)

Featured

UN issues 'red alert' over 'catastrophe' in Sudan's El-Obeid

Police hunt for Ukrainian woman over Monaco bomb attack

Last news